European Medicines Agency's top official links AstraZeneca vaccine and thrombosis

European Medicines Agency's top official links AstraZeneca vaccine and thrombosis
AFP
Share
Font Size
Save
Comment
Synopsis

After several countries suspended the use of the jab -- including Italy -- the EMA declared that the benefits outweigh the risks and it should remain in use.

Agencies
AstraZeneca vaccine
A top official in the European Medicines Agency said in an interview published Tuesday that there is a link between the coronavirus vaccine and blood clots.

"In my opinion, we can say it now, it is clear there is a link with the vaccine. But we still do not know what causes this reaction," head of vaccines Marco Cavaleri told Italy's Il Messaggero newspaper.

He said that "in the next few hours, we will say that there is a connection, but we still have to understand how this happens".

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population have undermined confidence in the beleaguered vaccine.

After several countries suspended the use of the jab -- including Italy -- the EMA declared that the benefits outweigh the risks and it should remain in use.

But it has said that a causal link between clots and the vaccine is possible, and is expected to provide an updated assessment this week.

"We are trying to get a precise picture of what is happening, to define in detail this syndrome due to the vaccine," Cavaleri said.

He added: "Among the vaccinated, there are more cases of cerebral thrombosis... among young people than we would expect."

Read More News on

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

ETPrime stories of the day

Read before you invest. Insights on EMA India Ltd.. Explore Now